Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Anticancer Research|August 6, 2005
Hepatocellular carcinoma in hepatectomized patients: biologic and therapeutic implicationsThomas Makatsoris, Theodore Petsas, Athanassios C Tsamandas, et al.
Prenatal Diagnosis|February 14, 2006
Prenatal diagnosis of achondroplasia presenting with multiple-suture synostosis: a novel associationCharalampos Karadimas, Dimitrios Trouvas, George Haritatos, et al.
Anticancer Research|January 30, 2003
Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology GroupD Pectasides, G Fountzilas, A Rigopoulos, et al.
International Journal of Pharmaceutics|February 11, 2025
Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technologyHao-Ying Li, Abhimata Paramanandana, Sally Yunsun Kim, et al.
Mediterranean Journal of Rheumatology|July 18, 2020
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective studyDimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, et al.
European Journal of Neurology|October 26, 2005
The impact of paclitaxel or cisplatin-based chemotherapy on sympathetic skin response: a prospective studyA A Argyriou, A Koutras, P Polychronopoulos, et al.
Cancers|May 21, 2020
PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) InhibitorsFoteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, et al.
Translational Oncology|October 19, 2020
NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease developmentAnna Antonacopoulou, Anastasia E Kottorou, Foteinos-Ioannis Dimitrakopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2005
Impact of providing booklets about chemotherapy to newly presenting patients with cancer: a randomized controlled trialG Iconomou, A Viha, A Koutras, et al.
Genes|November 27, 2021
RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)Chaido Sirinian, Anastasios D Papanastasiou, Soren E Degn, et al.
Pageof 11